РЕКОМЕНДАЦИИ ПО ЭЛЕКТРОКАРДИОСТИМУЛЯЦИИ И СЕРДЕЧНОЙ РЕСИНХРОНИЗИРУЮЩЕЙ ТЕРАПИИ.ESC 2013

электрокардиостимуляция, сердечная ресинхронизирую- щая терапия, кардиостимулятор, сердечная недостаточность, синкопе, фибрилляция предсердий

1. Alboni P, Menozzi С, Brignole M, et al. Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. Circulation 1997;96:260-266.

2. Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data. Circulation 2006;114:11-17.

3. Nielsen JC, Thomsen PE, Hojberg S, et al. A comparison of single-lead atrial pacing with dual- chamber pacing in sick sinus syndrome. Eur Heart J 2011;32:686-696.

4. Brignole M, Deharo JC, DeRoyL, et al. Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block. J Am Coll Cardiol 2011;58:167-173.

5. Brignole M, Sutton R, Menozzi C, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006;27:1085-1092.

6. Breivik K, Ohm OJ, Segadal L. Sick sinus syndrome treated with permanent pacemaker in 109 patients. A follow-up study. Acta Med Scand 1979;206:153-159.

7. Hartel G, Talvensaari T. Treatment of sinoatrial syndrome with permanent cardiac pacing in 90 patients. Acta Med Scand 1975;198:341-347.

8. Rasmussen K. Chronic sinus node disease: natural course and indications for pacing. Eur Heart J 1981;2:455-459.

9. SasakiY Shimotori M, Akahane K, et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced, and physiologically paced groups. Pacing Clin Electrophysiol 1988;11:1575- 1583.

10. Andersen HR, Thuesen L, Bagger JP, et al. Prospective randomized trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-1528.

11. Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000;342:1385-1391.

12. Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus- node dysfunction. N Engl J Med 2002; 346:1854-1862.

13. Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998;338:1097-1104.

14. Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005;353:145-155.

15. Castelnuovo E, Stein K, Pitt M, et al. The effectiveness and costeffectiveness of dual- chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess 2005;9: III, XI-XIII, 1-246.

16. Sweeney MO, Bank AJ, Nsah E et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-1008.

17. Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-3123.

18. Sud S, Klein GJ, Skanes AC, et al. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope. Europace 2007;9:312-318.

19. Brignole M, Menozzi C, Moya A, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 2012;125:2566-2571.

20. Ammirati F, Colivicchi F, Santini M. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 2001;104:52-57.

21. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS).Arandomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999;33:16-20.

22. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003;289:2224-2229.

23. Raviele A, Giada F, Menozzi C, et al. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004;25:1741- 1748.

24. Литература

25. Sutton R, Brignole M, Menozzi C, et al. Dualchamber pacing in the treatment of neurally mediated tilt-positive cardio-inhibitory syncope: pacemaker versusno therapy: amulticenter randomized study.The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000;102:294-299.

26. Moya A, Garcia-Civera R, Croci F et al. Diagnosis, management, and outcomes of patients with syncope and bundle branch block. Eur Heart J 2011;32:1535-1541.

27. Scheinman MM, Peters RW, Suave MJ et al. Value of the H-Q interval in patients with bundle branch block and the role of prophylactic permanent pacing. Am J Cardiol 1982;50:1316-1322.

28. Gronda M, Magnani A, Occhetta E, et al. Electrophysiological study of atrio-ventricular block and ventricular conduction defects. Prognostic and therapeutical implications. G Ital Cardiol 1984;14:768-773.

29. Bergfeldt L, Edvardsson N, Rosenqvist M, et al. Atrioventricular block progression in patients with bifascicular block assessed by repeated electrocardiography and a bradycardia- detecting pacemaker Am J Cardiol 1994;74:1129-1132.

30. Dini P, Iaolongo D, Adinolfi E et al. Prognostic value of His-ventricular conduction after ajmaline administration. In: Masoni A, Albani P, (eds). Cardiac Electrophysiology Today. London: Academic Press; 1982, 515-522.

31. Kaul U, Dev V, Narula J, Malhotra AK, et al. Evaluation of patients with bundle branch block and 'unexplained' syncope: a study based on comprehensive electrophysiological testing and ajmaline stress. Pacing Clin Electrophysiol 1988; 11:289-297.

32. Twidale N, Heddle WF, Tonkin AM. Procainamide administration during electrophysiology study-utility as a provocative test for intermittent atrioventricular block. Pacing Clin Electrophysiol 1988;11:1388-1397.

33. Santini M, Castro A, Giada F, et al. Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study. Circ Arrhythm Electrophysiol. 2013;6: 101-107.

34. McAnulty JH, Rahimtoola SH, Murphy E, et al. Natural history of 'high-risk' bundle-branch block: final report of a prospective study. N Engl J Med 1982;307:137-143.

35. Peters RW, Scheinman MM, Modin C, et al. Prophylactic permanent pacemakers for patients with chronic bundle branch block. Am J Med 1979;66:978-985.

36. Brignole M, Menozzi C. The natural history of carotid sinus syncope and the effect of cardiac pacing. Europace 2011;13:462-464.

37. Brignole M, Menozzi C, Lolli G, Bottoni N, Gaggioli G. Long-termoutcome of paced and nonpaced patients with severe carotid sinus syndrome. Am J Cardiol 1992;69:1039-1043.

38. Claesson JE, Kristensson BE, Edvardsson N, Wahrborg P. Less syncope and milder symptoms in patients treated with pacing for induced cardio-inhibitory carotid sinus syndrome: a randomized study. Europace 2007;9:932-936.

39. Sugrue DD, Gersh BJ, Holmes DR Jr., et al. Symptomatic 'isolated' carotid sinus hypersensitivity: natural history and results of treatment with anticholinergic drugs or pacemaker J Am Coll Cardiol 1986;7:158-162.

40. Gaggioli G, Brignole M, Menozzi C, et al. A positive response to head-up tilt testing predicts syncopal recurrence in carotid sinus syndrome patients with permanent pacemakers. Am J Cardiol 1995;76:720-722.

41. Maggi R, Menozzi C, Brignole M, et al. Cardio-inhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope. Europace 2007;9:563- 567.

42. MadiganNP, Flaker GC, Curtis JJ, et al. Carotid sinus hypersensitivity: beneficial effects of dual-chamber pacing. Am J Cardiol 1984;53:1034-1040.

43. Brignole M, Sartore B, Barra M, et al. IsDDDsuperior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-term study. Pacing Clin Electrophysiol 1988;11:1902-1910.

44. Sutton R. Pacing in patients with carotid sinus and vasovagal syndromes. Pacing Clin Electrophysiol 1989;12:1260-1263.

45. Flammang D, Church TR, De Roy L, et al. Treatment of unexplained syncope: a multicenter randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing. Circulation 2012;125:31-36.

46. Parry SW, Steen N, Bexton RS, et al. Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial. Heart 2009;95:405-409.

47. Cleland JG, Freemantle N, Erdmann E et al. Long-term mortality with cardiac resynchronization therapy in the Cardiac Resynchronization-Heart Failure (CARE-HF) trial. Eur J Heart Fail 2012; 14:628-634.

48. Bogale N, Witte K, Priori S, et al. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail 2011;13:974-983.

49. Zareba W, Klein H, Cygankiewicz I, et al. Effectiveness of Cardiac Resynchronization Therapy byQRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011;123:1061-1072.

50. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.

51. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.

52. Auricchio A, Stellbrink C, Butter C, et al. Clinical efficacy of cardiac resynchronization therapy using left ventricular pacing in heart failure patients stratified by severity of ventricular conduction delay. J Am Coll Cardiol 2003;42:2109-2116.

53. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-880.

54. Higgins SL, Hummel JD, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-1459.

55. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-2694.

56. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150.

57. Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.

58. Al-Majed NS, McAlister FA, Bakal JA, Ezekowitz JA. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-412.

59. Sipahi I, Carrigan TP, RowlandDY et al. Impact ofQRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med 2011;171:1454-1462.

60. Gervais R, Leclercq C, Shankar A, et al. Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub-analysis of the CARE-HF trial. Eur J Heart Fail 2009;11:699-705.

61. AbrahamWT, Young JB, Leon AR, et al. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator; and mildly symptomatic chronic heart failure. Circulation 2004;110:2864-2868.

62. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843.

63. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395.

64. Gold MR, Thebault C, Linde C, et al. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodelling in Systolic Left Ventricular Dysfunction (REVERSE) study. Circulation 2012;126:822-829.

65. Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.AmHeart J 2012;163:260-267 e263.

66. Beshai JF Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-2471.

67. Thibault B, Harel F, Ducharme A, et al. LESSER-EARTH Investigators. Cardiac Resynchronization Therapy in Patients With Heart Failure and a QRS Complex,120 Milliseconds: The Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) Trial. Circulation 2013;127:873-881.

68. Koplan BA, Kaplan AJ, Weiner S, et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol 2009;53:355-360.

69. Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm 2011;8:1469-1475.

70. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing: insights from 32844 patients. Circ Arrhythm Electrophysiol 2012;5:884-888.

71. Saxon LA, Olshansky B, Volosin K, et al. Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol 2009;20:764-768.

72. Thebault C, Donal E, Meunier C, et al. Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J 2012;33:2662-2671.

73. Singh JP, Klein HU, Huang DT, et al. Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial. Circulation 2011;123:1159-1166.

74. Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012;59:1509-1518.

75. Sawhney NS, Waggoner AD, Garhwal S, et al. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm 2004;1:562-567.

76. Vidal B, Tamborero D, Mont L, et al. Electrocardiographic optimization of interventricular delay in cardiac resynchronization therapy: a simple method to optimize the device. J Cardiovasc Electrophysiol 2007;18:1252-1257.

77. AbrahamWT, Calo' L, Islam N, et al. Randomized controlled trial of frequent optimization of cardiac resynchronization therapy: results of the Frequent Optimization Study Using the QuickOptTM Method (FREEDOM) Trial. (in press).

78. Abraham WT, Leon AR, St John Sutton MG, et al. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy. Am Heart J 2012;164:735-741.

79. Boriani G, Muller CP, Seidl KH, et al. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II

80. implantable cardioverter defibrillator (RHYTHM II ICD) study. Am Heart J 2006;151:1050- 1058.

81. Ellenbogen KA, Gold MR, Meyer TE, et al. Primary results from the SmartDelay determined AV optimization: a comparison with other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy. Circulation 2010;122:2660-2668.

82. Leon AR, Abraham WT, Brozena S, et al. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure. J Am Coll Cardiol 2005;46:2298-2304.

83. Martin DO, Lemke B, Birnie D, et al. Investigation of a novel algorithm for synchronized left- ventricular pacing and ambulatory optimization of cardiac resynchronization therapy: results of the adaptive CRT trial. Heart Rhythm 2012;9:1807-1814.

84. Rao RK, Kumar UN, Schafer J, et al. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007;115:2136-2144.

85. Ritter P, Delnoy PP, Padeletti L, et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace 2012;14:1324-1333.

86. Gasparini M, Bocchiardo M, Lunati M, et al. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs. Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006;152:155 e151-e157.

87. Boriani G, Kranig W, Donal E, et al. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. Am Heart J 2010;159:1052-1058 e1051.

88. Liang Y, PanW, Su Y, Ge J. Meta-analysis of randomized controlled trials comparing isolated left ventricular and biventricular pacing in patients with chronic heart failure. Am J Cardiol 2011;108:1160-1165.

89. Thibault B, Ducharme A, Harel F, et al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex./j120 milliseconds. Circulation 2011;124:2874-2881.

90. Boriani G, Gardini B, Diemberger I, et al. Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. Eur J Heart Fail 2012;14:652-660.

91. Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 2011;32:2420-2429.

92. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002;23:1780-1787.

93. Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol 2008;52:1239- 1246.

94. Wilton SB, Leung AA, Ghali WA, et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 2011;8:1088-1094.

95. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol 2002;40:111-118.

96. Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160-1165.

97. Wein S, Voskoboinik A, Wein L, et al. Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients. J Card Fail 2010;16:432-438.

98. Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol 2009;53:1050-1055.

99. Tolosana JM, Hernandez Madrid A, Brugada J, et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol 2008;102:444-449.

100. Ferreira AM, Adragao P, CavacoDM, et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace 2008;10:809-815.

101. Ganesan AN, Brooks AG, Roberts-Thomson KC, et al. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol 2012;59:719-726.

102. Gasparini M, Auricchio A, Metra M, et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 2008;29:1644-1652.

103. Gasparini M, Auricchio A, Regoli F et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48:734-743.

104. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol 2004;94:1506-1509.

105. Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 2007;99:1252-1257.

106. Khadjooi K, FoleyPW, Chalil S, et al. Longterm effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008;94:879-883.

107. Orlov MV, Gardin JM, Slawsky M, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodelling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 2010;159:264-270.

108. Brignole M, Gammage M, Puggioni E, et al. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J 2005;26:712-722.

109. Brignole M, Botto GL, Mont L, et al. Predictors of clinical efficacy of 'Ablate and Pace' therapy in patients with permanent atrial fibrillation. Heart 2012;98:297-302.

110. Leclercq C, Cazeau S, Lellouche D, et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol 2007;30 Suppl 1: S23-30.

111. Delnoy PP, Ottervanger JP, Vos DH, et al. Upgrading to biventricular pacing guided by pressure- volume loop analysis during implantation. J Cardiovasc Electrophysiol 2011;22:677-683.

112. Hoijer CJ, Meurling C, Brandt J. Upgrade to biventricular pacing in patients with conventional pacemakers and heart failure: a double-blind, randomized crossover study. Europace 2006;8:51-55.

113. van Geldorp IE, Vernooy K, Delhaas T, et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace 2010;12:223-229.

114. Baker CM, Christopher TJ, Smith PF, et al. Addition of a left ventricular lead to conventional pacing systems in patients with congestive heart failure: feasibility, safety, and early results in 60 consecutive patients. Pacing Clin Electrophysiol 2002;25:1166-1171.

115. Eldadah ZA, Rosen B, Hay I, et al. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm 2006;3:435-442.

116. Laurenzi F, Achilli A, Avella A, Peraldo C, et al. Biventricular upgrading in patients with conventional pacing system and congestive heart failure: results and response predictors. Pacing Clin Electrophysiol 2007;30:1096-1104.

117. Leon AR, Greenberg JM, Kanuru N, et al. Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 2002;39:1258-1263.

118. Shimano M, Tsuji Y Yoshida Y et al. Acute and chronic effects of cardiac resynchronization in patients developing heart failure with longterm pacemaker therapy for acquired complete atrioventricular block. Europace 2007;9:869-874.

119. Valls-Bertault V, Fatemi M, Gilard M, et al. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation. Europace 2004;6:438-443.

120. Vatankulu MA, Goktekin O, Kaya MG, et al. Effect of long-term resynchronization therapyon left ventricular remodeling in pacemaker patients upgraded to biventricular devices. Am J Cardiol 2009;103:1280-1284.

121. Foley PW, Muhyaldeen SA, Chalil S, et al. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure. Europace 2009;11:495-501.

122. Frohlich G, Steffel J, Hurlimann D, et al. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodelling. Eur Heart J 2010;31:1477-1485.

123. Marai I, Gurevitz O, Carasso S, et al. Improvement of congestive heart failure by upgrading of conventional to resynchronization pacemakers. Pacing Clin Electrophysiol 2006;29:880-884.

124. Paparella G, Sciarra L, Capulzini L, et al. Long-term effects of upgrading to biventricular pacing: differences with cardiac resynchronization therapy as primary indication. Pacing Clin Electrophysiol 2010;33:841-849.

125. Albertsen AE, Nielsen JC, Poulsen SH, et al. Biventricular pacing preserves left ventricular performance in patients with high-grade atrio-ventricular block: a randomized comparison with DDD (R) pacing in 50 consecutive patients. Europace 2008;10:314-320.

126. Chan JY Fang F, Zhang Q, et al. Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 2011;32:2533-2540.

127. Curtis AB, Worley S Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. New Engl J Med 2013;368:1585-1593.

128. Curtis AB, Adamson PB, Chung E, et al. Biventricular versus right ventricular pacing in patients with AV block (BLOCKHF): clinical study design and rationale. J Cardiovasc Electrophysiol 2007;18:965-971.

129. Kindermann M, Hennen B, Jung J, et al. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol 2006;47:1927-1937.

130. Martinelli Filho M, de Siqueira SF, Costa R, et al. Conventional versus biventricular pacing in heart failure and bradyarrhythmia: the COMBAT study. J Card Fail 2010;16:293-300.

131. Stockburger M, Gomez-Doblas JJ, Lamas G, et al. Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multi-centre international randomized trial (PREVENT-HF). Eur J Heart Fail 2011;13:633-641.

132. Yu CM, Chan JY Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123-2134.

133. Lam SK, Owen A. Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomized controlled trials. BMJ 2007;335:925.

134. Gang UJ, Hvelplund A, Pedersen S, et al. High-degree atrioventricular block complicating ST-segment elevation myocardial infarction in the era of primary percutaneous coronary intervention. Europace 2012;14:1639-1645.

135. Behar S, Zissman E, Zion M, et al. Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction. SPRINT Study Group. Am J Cardiol 1993;72:831-834.

136. Col JJ, Weinberg SL. The incidence and mortality of intraventricular conduction defects in acute myocardial infarction. Am J Cardiol 1972;29:344-350.

137. Ginks WR, Sutton R, OhW, Leatham A. Long-term prognosis after acute anterior infarction with atrioventricular block. Br Heart J 1977;39:186-189.

138. Jim MH, Chan AO, Tse HF, et al. Clinical and angiographic findings of complete atrioventricular block in acute inferior myocardial infarction. Ann Acad Med Singapore 2010;39:185-190.

139. Gross GJ, Chiu CC, Hamilton RM, Kirsh JA, Stephenson EA. Natural history of postoperative heart block in congenital heart disease: implications for pacing intervention. Heart Rhythm 2006;3:601-604.

140. Krongrad E. Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 1978;57:867-870.

141. Murphy DA, Tynan M, Graham GR, Bonham-Carter RE. Prognosis of complete atrioventricular dissociation in children after open-heart surgery. Lancet 1970;1:750-752.

142. Squarcia U, Merideth J, McGoon DC, Weidman WH. Prognosis of transient atrioventricular conduction disturbances complicating open heart surgery for congenital heart defects. Am J Cardiol 1971;28:648-652.

143. Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol 1998;82:525-527.

144. Chang SM, Nagueh SF, Spencer WH3rd, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 2003;42:296-300.

145. Topilski I, Sherez J, Keren G, Copperman I. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy.50 years of age. Am J Cardiol 2006;97:1769-1775.

146. Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J 1997;18:1249-1256.

147. Maron BJ, Nishimura RA, McKenna WJ, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation 1999;99:2927-2933.

148. Nishimura RA, Trusty JM, Hayes DL, et al. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 1997;29:435-441.

149. Galve E, Sambola A, Saldana G, et al. Late benefits of dual-chamber pacing in obstructive hypertrophic cardiomyopathy: a 10-year follow-up study. Heart 2010;96:352-356.

150. Megevand A, Ingles J, Richmond DR, Semsarian C. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. Am J Cardiol 2005;95:991-993.

151. IsraelCW, Hugl B, Unterberg C, et al. Pacetermination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol 2001;12:1121-1128.

152. Blanc JJ, De Roy L, Mansourati J, et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 2004;6:371-379.

153. Carlson MD, Ip J, Messenger J, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-633.

154. Gold MR, Adler S, Fauchier L, et al. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009;6:295-301.

155. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120-129.

156. Hohnloser SH, Healey JS, Gold MR et al. Atrial overdrive pacing to prevent atrial fibrillation: insights fromASSERT. Heart Rhythm2012;9:1667-1673.

157. IsraelCW, Gronefeld G, Ehrlich JR, et al. Prevention of immediate reinitiation of atrial tachyarrhythmias by high-rate overdrive pacing: results from a prospective randomized trial. J Cardiovasc Electrophysiol 2003;14:954-959.

158. Kantharia BK, Freedman RA, Hoekenga D, et al. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study. Europace 2007;9:1024-1030.

159. Lee MA, Weachter R, Pollak S, et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926-1932.

160. Mont L, Ruiz-Granell R, Martinez JG, et al. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial. Europace 2008;10:28-34.

161. Sulke N, Silberbauer J, Boodhoo L, et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace 2007;9:790-797.

162. Burke PT, Ghanbari H, Alexander PB, et al. Aprotocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post- (MRI). J Interv Card Electrophysiol 2010;28:59-66.

163. Del Ojo JL, Moya F, Villalba J, et al. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol 2005; 28:274-278.

164. Gimbel JR, Kanal E, Schwartz KM, Wilkoff BL. Outcome of magnetic resonance imaging (MRI) in selected patients with implantable cardioverter defibrillators (ICDs). Pacing Clin Electrophysiol 2005;28:270-273.

165. Halshtok O, Goitein O, Abu Sham'a R, et al. Pacemakers and magnetic resonance imaging: no longer an absolute contra-indication when scanned correctly. Isr Med Assoc J 2010;12:391-395.

166. Martin ET, Coman JA, Shellock FG, et al. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. JAmCollCardiol 2004;43:1315-1324.

167. Mollerus M, Albin G, Lipinski M, Lucca J. Cardiac biomarkers in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan. Pacing Clin Electrophysiol 2008;31:1241-1245.

168. Mollerus M, Albin G, Lipinski M, Lucca J. Magnetic resonance imaging of pacemakers and implantable cardioverter-defibrillators without specific absorption rate restrictions. Europace 2010;12:947-951.

169. Naehle CP, Meyer C, Thomas D, et al. Safety of brain 3-T MR imaging with transmit-receive head coil in patients with cardiac pacemakers: pilot prospective study with 51 examinations. Radiology 2008;249:991-1001.

170. Naehle CP, Strach K, Thomas D, et al. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2009;54:549-555.

171. Naehle CP, Zeijlemaker V, Thomas D, et al. Evaluation of cumulative effects of MR imaging on pacemaker systems at 1.5 Tesla. Pacing Clin Electrophysiol 2009;32:1526-1535.

172. Nazarian S, Hansford R, Roguin A, et al. A prospective evaluation of a protocol for magnetic resonance imaging of patients with implanted cardiac devices. Ann Intern Med 2011;155:415-424.

173. Sommer T, Naehle CP, Yang A, et al. Strategy for safe performance of extrathoracic magnetic resonance imaging at 1.5 tesla in the presence of cardiac pacemakers in non- pacemaker-dependent patients: a prospective study with 115 examinations. Circulation 2006;114:1285-1292.

174. Strach K, Naehle CP, Muhlsteffen A, et al. Low-field magnetic resonance imaging: increased safety for pacemaker patients? Europace 2010;12:952-960.

175. Wilkoff BL, Bello D, Taborsky M, et al. Magnetic resonance imaging in patients with a pacemaker system designed for the magnetic resonance environment. Heart Rhythm 2011;8:65-73.

176. Crossley GH, Boyle A, Vitense H, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol 2011;57:1181-1189.

177. Landolina M, Perego GB, Lunati M, et al. Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 2012;125:2985-2992.

178. Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010;122:325-332.